Efficacy of Compound GV-350 with Tricofer Iron, Cystine, and Biotin in the Management of Telogen Effluvium in Women with Iron Deficiency
November 2025
Studysummary In this study, GV-350 treatment over three months improved iron status and reduced the impact of Telogen Effluvium on quality of life among 20 iron-deficient women, with no adverse events reported.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on doi.org →